COMPANY PROFILE / #2259
Kimia(Discovery Tools (Healthcare))
Berkeley, CAVenture Capital-Backed
OVERVIEW
Developer of a drug discovery platform intended to cater to the areas of oncology, immunology, and inflammation. The company's platform helps apply high throughput precision chemistry in combination with genome editing and machine learning to identify drugable sites at key nodes of intervention in human disease and to generate datasets that reveal the molecular features of active and inactive drug molecules and through machine learning generate algorithms and feature maps, helping clients accelerate the discovery of drugs for novel and challenging targets.
已融资57.23
最新估值75.00
员工数35
成立年份2023
公司概况
- Companies
- Kimia(Discovery Tools (Healthcare))
- Description
- Developer of a drug discovery platform intended to cater to the areas of oncology, immunology, and inflammation. The company's platform helps apply high throughput precision chemistry in combination with genome editing and machine learning to identify drugable sites at key nodes of intervention in human disease and to generate datasets that reveal the molecular features of active and inactive drug molecules and through machine learning generate algorithms and feature maps, helping clients accelerate the discovery of drugs for novel and challenging targets.
- Website
- www.kimiatx.com
- HQ Location
- Berkeley, CA
- Year Founded
- 2023
- Keywords
- biotechnology research, chemoproteomics technology, drug discovery engine, medicine maker, precision product, transcriptomics data analysis
- Competitors
- Maze Therapeutics, Eikon Therapeutics
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 57.23
- First Financing Date
- 01-Jan-2023
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 19-Dec-2023
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 55.00
- Last Financing Valuation
- 75.00
- Last Financing Status
- Completed
- Last Known Valuation
- 75.00
- Last Known Valuation Date
- 19-Dec-2023
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 117.96
- Valuation Estimate Growth Rate
- 57.28%
- Active Investors
- Dimension (United States), Horizons Ventures, The Column Group
- # Active Investors
- 3
- Acquirers
- —
团队与联系人
- Employees
- 35
- Employee Growth %
- 12.90%
- Employee History
- 2025: 35, 2024: 31, 2023: 16
- Primary Contact
- Stig Hansen
- Primary Contact Title
- Co-Founder, Chief Executive Officer, Board Member and President
- Primary Contact Email
- shansen@kimiatx.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 2.85x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 74
- Majestic Referring Domains
- 74
- SimilarWeb Unique Visitors
- 293
- SimilarWeb Unique Visitors Change
- 15
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 8%
- Success Probability Over Time – 3 Year
- 23%
- Success Probability Over Time – 5 Year
- 35%
记录来源:public.companies · 原始序号 #2259 · 所有字段均按数据库原值展示。